Translational Development Acquisition TDACU

NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) stock price is $11.48, unchanged on the day, as of Nov 5, 2026. It has a market cap of $233.68Mn and a P/E ratio of 42.21, and is classified in the Investment Banking industry (Financial Services sector).

Key Stats
Market Cap233.68 Mn
P/E42.21
FCF (Yr)-608,387.00
ROA (Yr)3.57
EV to EBIT-177.13
Net Income (Yr)6.36 Mn
Enterprise Value233.49 Mn
Add ratio to table…

About

Translational Development Acquisition Corp. is a blank check company incorporated as a special purpose acquisition company. The company was formed with the sole purpose of effecting a merger capital stock exchange asset acquisition stock purchase reorganization or similar business combination with one or more businesses. It has not commenced any commercial operations and does not produce or sell any products or services. The company is considered a development stage entity…

Read more ↓
Sector: Financial Services Sector rationale The company is a Special Purpose Acquisition Company (SPAC), which is a vehicle designed to raise capital through an IPO to acquire another business. Its sole activity is managing a trust account invested in government securities and seeking a merger target, which falls under the 'Specialty Finance' or 'Asset Management' functions of the Financial Services sector. Industry: Investment Banking Investment Banking Primary The company is a Special Purpose Acquisition Company (SPAC) whose sole purpose is to effect a merger, asset acquisition, or business combination. This activity of identifying targets, negotiating deals, and executing capital raises for a business combination aligns with the advisory and underwriting functions of investment banking. Classified using BQ-MICS CIK: 0001926599
Peer percentiles

How Translational Development Acquisition ranks

Ranked against the 110 companies in Capital Markets58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 42.2xMedian 28.4x 52nd
  • P/FCFNegative free cash flow −366xMedian 15.1x 46th
  • P/Operating cash flowNegative operating cash flow −366xMedian 13.6x 43rd
  • P/S —Median 2.91x No data —
  • P/BNegative shareholder equity −40.5xMedian 2.32x Not meaningful —
  • P/Tangible bookNegative tangible equity −40.5xMedian 3.28x Not meaningful —
  • EV/EBITDA —Median 13.2x No data —
  • EV/EBITNegative EBIT −237xMedian 16.5x 35th
  • EV/Revenue —Median 3.26x No data —
  • EV/FCFNegative free cash flow −367xMedian 18.3x 42nd
  • EV/Operating cash flowNegative operating cash flow −367xMedian 17.0x 42nd
  • PEG (3Y EPS CAGR) —Median 0.47 No data —
Peer group

Peer Comparison

Companies in the Investment Banking
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 CME Cme Group Inc. 109.59 Bn24.8215.723.43 Bn
2 BNY Bank of New York Mellon Corp 100.46 Bn15.964.5741.16 Bn
3 ICE Intercontinental Exchange, Inc. 97.18 Bn23.356.9223.30 Bn
4 HOOD Robinhood Markets, Inc. 72.63 Bn36.6114.292.66 Bn
5 NDAQ Nasdaq, Inc. 59.89 Bn28.746.558.74 Bn
6 STT State Street Corp 45.42 Bn13.172.93-
7 CBOE Cboe Global Markets, Inc. 36.91 Bn25.036.991.44 Bn
8 TDAC Translational Development Acquisition Corp. 0.23 Bn42.21-0.00 Bn